06 Feb 2026 Pre-Market: SGSN.SW SGS S.A. (SIX) CHF91.84 before Feb 11 earnings: analysts’ focus
The SGSN.SW stock opens pre-market at CHF91.84, down 1.52% from yesterday’s close. Investors focus on the company’s 11 Feb 2026 earnings release and guidance for testing and certification demand. Key metrics to watch are EPS 3.23, PE 29.63, and trailing volumes near 347573.00 shares. We outline what the upcoming report could mean for pricing, valuation, and dividend signals ahead of the SIX session. This earnings spotlight frames near-term catalysts and model-based forecasts to help shape trading and portfolio decisions.
SGSN.SW stock: Earnings calendar & what to expect
SGS S.A. reports results on 11 Feb 2026. The market will watch organic revenue trends in Health & Nutrition and Natural Resources. Analysts will zero in on margin progress and any commentary on lab capacity and pricing.
Management commentary on backlog and commodity testing volumes could swing the stock intraday. Expect volatility given current RSI and event-driven flows.
Key financials and valuation for SGSN.SW stock
SGS S.A. shows EPS 3.23 and a reported PE 29.63 on a market cap of CHF18,528,102,678.00. Trailing metrics include a 50-day average price CHF91.83 and 200-day average CHF86.45.
The dividend per share is CHF3.20, yielding about 3.34%. Balance-sheet ratios show interest coverage 8.99 and current ratio 1.13, while debt to equity runs high by book metrics. These figures frame valuation versus the Industrials sector average PE 28.86.
Meyka stock grade & forecast for SGSN.SW stock
Meyka AI rates SGSN.SW with a score of 70.71/100 (Grade B+, Suggestion: BUY). This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, and analyst signals.
Meyka AI’s forecast model projects a yearly target CHF96.38, implying an upside of 4.94% versus the current CHF91.84. Monthly and three-year model figures sit at CHF102.30 and CHF103.30 respectively. Forecasts are model-based projections and not guarantees. These grades are not guaranteed and we are not financial advisors.
Technical setup and trading cues for SGSN.SW stock
Momentum reads overbought: RSI 72.43, Stochastic %K 97.72. Volatility indicators show ATR 1.42 and Bollinger upper band CHF95.64. Short-term trend is positive but vulnerable to post-earnings pullback.
Volume is above average at 347573.00 versus avg 335001.00. Traders should watch a break above CHF95.00 for continuation or a failure below CHF91.26 for a quick move to the 200-day average.
Sector context, risks, and drivers for SGSN.SW stock
SGS operates in Industrials consulting and testing services. The sector average PE is 28.86, placing SGS near peer valuation. Demand from food, life sciences, and mining drives revenue resilience.
Key risks include high reported debt-to-equity metrics and receivables days near 88.81. Macroeconomic slowdowns or weaker industrial activity would hurt testing volumes and margins.
Price targets and analyst scenarios for SGSN.SW stock
We offer three scenario price targets in CHF. Conservative: CHF88.00 (downside -4.19%). Base: CHF97.00 (upside 5.61%). Bullish: CHF110.00 (upside 19.76%).
These targets reflect EPS of 3.23, sector PE comparatives, and the company’s cash flow yield. Use the mid-case if earnings beat consensus and management signals sustained margin improvement.
Final Thoughts
SGSN.SW stock traders face a binary earnings event on 11 Feb 2026 that can reset near-term direction. Key anchors are reported EPS 3.23, PE 29.63, and dividend yield 3.34%. Our model gives a one-year projection of CHF96.38, an implied upside of 4.94% from CHF91.84. Short-term technicals look stretched but the company benefits from diversified testing demand across Health & Nutrition and Natural Resources. Balance-sheet leverage and receivables timing remain notable risks. For active traders, watch intraday volume and a close above CHF95.00. For longer-term investors, the Meyka grade B+ (70.71/100) and cash flow metrics support a selective BUY stance, but forecasts are model-based and not guarantees. For the company’s investor materials see SGS investor site and for live quotes visit our platform at Meyka stock page. Meyka AI is an AI-powered market analysis platform providing model-driven views to inform research.
FAQs
When does SGSN.SW report earnings and why does it matter?
SGS S.A. reports earnings on 11 Feb 2026. The release matters because management guidance on testing volumes and margins will affect revenue growth and the stock’s short-term volatility.
What are the key metrics to watch in the SGSN.SW earnings report?
Monitor organic revenue, operating margin, EPS versus 3.23, commentary on lab capacity, and dividend outlook. Changes in receivables or backlog are also critical for cash flow.
What is Meyka AI’s near-term forecast for SGSN.SW stock?
Meyka AI’s forecast model projects a yearly price of CHF96.38, implying about 4.94% upside from CHF91.84. Forecasts are model-based projections and not guarantees.
How should investors use the Meyka grade for SGSN.SW stock?
Meyka AI rates SGSN.SW 70.71/100 (B+, BUY). Use it as one input alongside fundamentals, cash flow, and earnings outcomes. These grades are not guaranteed and not financial advice.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.